Online Education | Adult/Geriatric Drug Therapy 2016 - Risks and Benefits of PSA Screening for Prostate Cancer
This module is designed as an update on practice changes in the management of localized prostate cancer and the potential impact on the harms and benefits of PSA screening.
John L. Gore, MD, MS
Associate Professor, Urology, University of Washington Medical Center, Seattle
Comments from lecture attendees:
"Fantastic. Dr. Gore’s review of recent PSA confusing guidelines was very, very helpful. I will share this information."
"The PSA lecture was one of the best that I have attended."
For adult nurse practitioners, geriatric nurse practitioners, family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
After taking this module, you will be better able to:
1. Recognize the harms associated with PSA screening.
2. Discuss the limitations of US and European screening trials.
3. Describe populations that may benefit from PSA screening.
- 1.10 Contact hours
- 1.10 Pharmacology hours at the advanced practice level